Cargando…

Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review

Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which may partly explain why it remains still orphan of an adequate therapeutic strategy. Herein we focus on the interplay between oxidative stress (OS) and the other causal pathogenetic factors. Different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delli Bovi, Anna Pia, Marciano, Francesca, Mandato, Claudia, Siano, Maria Anna, Savoia, Marcella, Vajro, Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952971/ https://www.ncbi.nlm.nih.gov/pubmed/33718398 http://dx.doi.org/10.3389/fmed.2021.595371

Ejemplares similares

Editorial: The broader aspects of non-alcoholic fatty liver disease in children
por: Mandato, Claudia, et al.
Publicado: (2022)

More on Current Evidences on Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver Disease
por: Vajro, Pietro, et al.
Publicado: (2013)

Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions
por: Clemente, Maria Grazia, et al.
Publicado: (2016)

Pediatric Fatty Liver and Obesity: Not Always Just a Matter of Non-Alcoholic Fatty Liver Disease
por: Alfani, Renata, et al.
Publicado: (2018)

Obesity and Obesity Related Diseases, Sugar Consumption and Bad Oral Health: A Fatal Epidemic Mixtures: The Pediatric and Odontologist Point of View.
por: Delli Bovi, Anna Pia, et al.
Publicado: (2017)

Pediatric Acute Liver Failure
por: Mandato, Claudia, et al.
Publicado: (2023)

Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome
por: Troisi, Jacopo, et al.
Publicado: (2019)

Nutrition and Liver Disease
por: Mandato, Claudia, et al.
Publicado: (2017)

Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease
por: Poeta, Marco, et al.
Publicado: (2017)

Drug dosing in children with obesity: a narrative updated review
por: Gaeta, Francesca, et al.
Publicado: (2022)

Monkeypox Infection 2022: An Updated Narrative Review Focusing on the Neonatal and Pediatric Population
por: Gaeta, Francesca, et al.
Publicado: (2022)

Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection
por: Mandato, Claudia, et al.
Publicado: (2021)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Cholestatic jaundice in infancy: struggling with many old and new phenotypes
por: Mandato, Claudia, et al.
Publicado: (2019)

Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update
por: Li, Na, et al.
Publicado: (2021)

Pediatric non alcoholic fatty liver disease: more on novel treatment targets
por: Vajro, Pietro, et al.
Publicado: (2013)

A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant
por: Mandato, Claudia, et al.
Publicado: (2021)

Genetics, epigenetics and transgenerational transmission of obesity in children
por: Panera, Nadia, et al.
Publicado: (2022)

Waist Circumference and Healthy Lifestyle Preferences/Knowledge Monitoring in a Preschool Obesity Prevention Program
por: Poeta, Marco, et al.
Publicado: (2019)

Hypoxia and Non-alcoholic Fatty Liver Disease
por: Isaza, Stephania C., et al.
Publicado: (2020)

An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease
por: Rodríguez-Sanabria, J. Samael, et al.
Publicado: (2022)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
por: Idalsoaga, Francisco, et al.
Publicado: (2020)

Healthy Lifestyle Management of Pediatric Obesity with a Hybrid System of Customized Mobile Technology: The PediaFit Pilot Project
por: Delli Bovi, Anna Pia, et al.
Publicado: (2021)

Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
por: Vajro, Pietro, et al.
Publicado: (2012)

Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome
por: Casale, Maddalena, et al.
Publicado: (2020)

Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases
por: Malhotra, Pooja, et al.
Publicado: (2020)

Vitamin D Levels in the Pre- and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age
por: Mosca, Caterina, et al.
Publicado: (2023)

Knowing What’s Out There: Awareness of Non-Alcoholic Fatty Liver Disease
por: Ghevariya, Vishal, et al.
Publicado: (2014)

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
por: Fridén, Michael, et al.
Publicado: (2022)

Multiple Sclerosis—Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics
por: Mandato, Claudia, et al.
Publicado: (2023)

Atypically Protracted Course of Liver Involvement in Kawasaki Disease. Case Report and Literature Review
por: Paglia, Pamela, et al.
Publicado: (2021)

Mini review: STING activation during non-alcoholic fatty liver disease
por: Li, Honggui, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease: an update on diagnosis
por: DUMITRASCU, DAN L., et al.
Publicado: (2018)

Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review
por: Siano, Maria Anna, et al.
Publicado: (2021)

Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease
por: Funuyet-Salas, Jesús, et al.
Publicado: (2020)

Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Holzner, Lorenz M. W., et al.
Publicado: (2021)

The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Wongtrakul, Wasit, et al.
Publicado: (2021)

Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients
por: Sugimoto, Ryosuke, et al.
Publicado: (2023)

Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis
por: Hoebinger, Constanze, et al.
Publicado: (2022)

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
por: Heyens, Leen J. M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b1p3u5nkrci99qrrf34jepjkbd